However, we do not exclude the possibility that the effects of XO inhibitors on CL diet-induced NAFLD are mediated by NLRP3 inflammasome-dependent mechanisms, since the efficacy and mechanism of action of XO inhibitors against NAFLD might be dependent on the dietary model. The gene discussed is XDH; the disease is metabolic dysfunction-associated steatotic liver disease.